When the dollar is strong, a U.S.-based company that sells products overseas earns fewer dollars. On the flip side, the cost of imported goods and foreign expenses are lower.
The lawsuit was filed this month by a senior sales representative who worked for Eli Lilly for 11 years before resigning in June. The complaint seeks class-action status on behalf of thousand of employees and former employees of Lilly.
The Indianapolis-based drugmaker said it has reached a definitive agreement to acquire Akouos Inc., a seven-year-old biotech firm, which is running early clinical trials for its lead therapy for hearing loss.
The IU School of Medicine announced won a five-year, $48.8 million grant from the National Institute on Aging, a division of the National Institutes of Health, to create in mice genetic mutations similar to those found in people with late-onset Alzheimer’s.
To meet the water demands of an innovation district planned for just north of Lebanon, state officials are exploring the idea of tapping into the Wabash aquifer in Tippecanoe County.
The Lebanon City Council on Monday night approved an agreement that would reserve water and wastewater for a $2.1 billion Eli Lilly and Co. development in Boone County.
In a significant expansion of their longstanding collaboration, the partners hope to develop new models for delivering therapies to patients and provide full tuition to between 75 and 100 students each year for 10 years.
Ultimately, no part of the state should become economically parched due to the lack of an adequate water supply. And care must be taken to make sure existing aquifers aren’t overtaxed or abused.
Purdue University has rehired Dan Hasler to coordinate the school’s expansion in Indianapolis following an August decision to split IUPUI into separate Indiana University and Purdue operations.
Twitter’s relaunched premium service—which grants blue-check “verification” labels to anyone willing to pay $8 a month—was unavailable Friday after the social media platform was flooded by a wave of impostor accounts.
Gantenerumab’s demise is a boost for Indianapolis-based Eli Lilly and Biogen, which are also developing treatments for Alzheimer’s, said Tim Anderson, an analyst at Wolfe Research. Lilly shares were up 1.8% at midday.
By Friday morning, Eli Lilly executives had ordered a halt to all Twitter ad campaigns—a potentially serious blow, given that the $330 billion company controls the kind of massive advertising budget that Musk says the company needs to avoid bankruptcy.
With the county experiencing the second-highest growth rate in Indiana, builders and apartment developers have not been able to meet the increasing demand for affordable and workforce housing.
Corteva Inc., the Indianapolis-based seed and insecticide giant, is cutting 5% of its global workforce, or roughly 1,000 workers, as it reduces its portfolio of products and streamlines its operations.
